← FDA Drug Approvals (Drugs@FDA)

DYAZIDE

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 1965-12-02

Drug application

FDA Application #

NDA016042

Application type

New Drug Application

Brand name

DYAZIDE

Generic name

Hydrochlorothiazide

Active ingredients

HYDROCHLOROTHIAZIDE; TRIAMTERENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE LLC

First approval

1965-12-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown